|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
OLC1919976787 |
| 003 |
DE-627 |
| 005 |
20230511173811.0 |
| 007 |
tu |
| 008 |
130516s2013 xx ||||| 00| ||und c |
| 028 |
5 |
2 |
|a sw130515_2
|
| 035 |
|
|
|a (DE-627)OLC1919976787
|
| 035 |
|
|
|a (DE-599)GBVOLC1919976787
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 082 |
0 |
4 |
|a 610
|
| 084 |
|
|
|a XA 10000
|q AVZ
|2 rvk
|
| 084 |
|
|
|a 44.81
|2 bkl
|
| 100 |
1 |
|
|a Drew, Yvette
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Therapeutic Potential of Poly(ADP-ribose) Polymerase Inhibitor AG014699 in Human Cancers With Mutated or Methylated BRCA1 or BRCA2
|
| 264 |
|
1 |
|c 2013
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 700 |
1 |
|
|a Mulligan, Evan A.
|4 oth
|
| 700 |
1 |
|
|a Vong, Wan-Tse
|4 oth
|
| 700 |
1 |
|
|a Thomas, Huw D.
|4 oth
|
| 700 |
1 |
|
|a Kahn, Samra
|4 oth
|
| 700 |
1 |
|
|a Kyle, Suzanne
|4 oth
|
| 700 |
1 |
|
|a Mukhopadhyay, Asima
|4 oth
|
| 700 |
1 |
|
|a Los, Gerrit
|4 oth
|
| 700 |
1 |
|
|a Hostomsky, Zdenek
|4 oth
|
| 700 |
1 |
|
|a Plummer, Elizabeth R.
|4 oth
|
| 700 |
1 |
|
|a Edmondson, Richard J.
|4 oth
|
| 700 |
1 |
|
|a Curtin, Nicola J.
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|t Journal of the National Cancer Institute
|d Cary, NC : Oxford Univ. Press, 1941
|g 103(2013), 4 vom: 10. Mai, Seite 334-333
|w (DE-627)129078077
|w (DE-600)2992-0
|w (DE-576)014410621
|x 0027-8874
|7 nnns
|
| 773 |
1 |
8 |
|g volume:103
|g year:2013
|g number:4
|g day:10
|g month:05
|g pages:334-333
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_OLC
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OLC-DE-84
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_55
|
| 912 |
|
|
|a GBV_ILN_252
|
| 912 |
|
|
|a GBV_ILN_2179
|
| 912 |
|
|
|a GBV_ILN_2181
|
| 912 |
|
|
|a GBV_ILN_4012
|
| 912 |
|
|
|a GBV_ILN_4112
|
| 912 |
|
|
|a GBV_ILN_4125
|
| 912 |
|
|
|a GBV_ILN_4219
|
| 912 |
|
|
|a GBV_ILN_4305
|
| 936 |
r |
v |
|a XA 10000
|
| 936 |
b |
k |
|a 44.81
|q AVZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 103
|j 2013
|e 4
|b 10
|c 5
|h 334-333
|
